Related Experiment Videos
Summary
Piperacillin exhibits dose-dependent pharmacokinetics in healthy volunteers, with clearance decreasing and AUC increasing with higher doses. This suggests capacity-limited kinetics, a trait common among ureidopenicillins.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Drug Metabolism
Background:
- Piperacillin is a broad-spectrum ureidopenicillin antibiotic.
- Understanding its pharmacokinetic profile is crucial for optimizing therapeutic efficacy and safety.
Purpose of the Study:
- To evaluate the pharmacokinetics of piperacillin at different dosage levels.
- To determine if piperacillin exhibits dose-dependent pharmacokinetic properties.
Main Methods:
- A pharmacokinetic study was conducted in 12 healthy volunteers.
- Volunteers were divided into three groups, each receiving piperacillin at doses of 15, 30, or 60 mg/kg body weight.
- Serum concentrations and urinary excretion were measured to determine pharmacokinetic parameters.
Main Results:
- Piperacillin demonstrated dose-dependent pharmacokinetics.
- Serum half-life ranged from 0.8 to 1.0 h.
- Total body clearance decreased with increasing doses (18.53 to 13.53 l/h normalized to 70 kg).
- Area under the serum concentration-time curve (AUC) increased with higher doses (57.1 to 79.6 µg·mL/g).
- Urinary elimination of unchanged piperacillin increased from 50.0% to 71.3% of the dose as dosage increased from 15 to 60 mg/kg.
Conclusions:
- Piperacillin displays dose-dependent pharmacokinetics in humans.
- The observed capacity-limited kinetics is consistent with other ureidopenicillins.
- These findings have implications for piperacillin dosing strategies.